vs

Side-by-side financial comparison of Stereotaxis, Inc. (STXS) and TRANSACT TECHNOLOGIES INC (TACT). Click either name above to swap in a different company.

TRANSACT TECHNOLOGIES INC is the larger business by last-quarter revenue ($11.5M vs $8.6M, roughly 1.3× Stereotaxis, Inc.). On growth, Stereotaxis, Inc. posted the faster year-over-year revenue change (36.3% vs 11.9%). Over the past eight quarters, Stereotaxis, Inc.'s revenue compounded faster (12.1% CAGR vs 3.5%).

Stereotaxis Inc. is an American publicly traded medical technology company based in St. Louis, Missouri, that makes robotic systems used by physicians to perform minimally-invasive endovascular procedures, including electrophysiology studies and cardiac catheter ablation procedures.

Roper Technologies, Inc. is a holding company that owns companies in the technology sector.

STXS vs TACT — Head-to-Head

Bigger by revenue
TACT
TACT
1.3× larger
TACT
$11.5M
$8.6M
STXS
Growing faster (revenue YoY)
STXS
STXS
+24.4% gap
STXS
36.3%
11.9%
TACT
Faster 2-yr revenue CAGR
STXS
STXS
Annualised
STXS
12.1%
3.5%
TACT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
STXS
STXS
TACT
TACT
Revenue
$8.6M
$11.5M
Net Profit
$-5.5M
Gross Margin
50.1%
47.6%
Operating Margin
-65.4%
-10.1%
Net Margin
-64.0%
Revenue YoY
36.3%
11.9%
Net Profit YoY
26.4%
EPS (diluted)
$-0.06
$-0.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
STXS
STXS
TACT
TACT
Q4 25
$8.6M
$11.5M
Q3 25
$7.5M
$13.2M
Q2 25
$8.8M
$13.8M
Q1 25
$7.5M
$13.1M
Q4 24
$6.3M
$10.2M
Q3 24
$9.2M
$10.9M
Q2 24
$4.5M
$11.6M
Q1 24
$6.9M
$10.7M
Net Profit
STXS
STXS
TACT
TACT
Q4 25
$-5.5M
Q3 25
$-6.5M
$15.0K
Q2 25
$-3.8M
$-143.0K
Q1 25
$-5.8M
$19.0K
Q4 24
$-7.5M
Q3 24
$-6.2M
$-551.0K
Q2 24
$-5.8M
$-319.0K
Q1 24
$-4.5M
$-1.0M
Gross Margin
STXS
STXS
TACT
TACT
Q4 25
50.1%
47.6%
Q3 25
54.9%
49.8%
Q2 25
52.0%
48.2%
Q1 25
54.4%
48.7%
Q4 24
50.7%
44.2%
Q3 24
44.6%
48.1%
Q2 24
73.6%
52.7%
Q1 24
57.6%
52.6%
Operating Margin
STXS
STXS
TACT
TACT
Q4 25
-65.4%
-10.1%
Q3 25
-87.8%
0.1%
Q2 25
-45.2%
-1.9%
Q1 25
-79.3%
-0.1%
Q4 24
-120.3%
-10.3%
Q3 24
-69.0%
-7.7%
Q2 24
-133.7%
-3.8%
Q1 24
-69.0%
-12.2%
Net Margin
STXS
STXS
TACT
TACT
Q4 25
-64.0%
Q3 25
-86.6%
0.1%
Q2 25
-43.5%
-1.0%
Q1 25
-77.9%
0.1%
Q4 24
-118.5%
Q3 24
-67.3%
-5.1%
Q2 24
-129.6%
-2.8%
Q1 24
-65.5%
-9.7%
EPS (diluted)
STXS
STXS
TACT
TACT
Q4 25
$-0.06
$-0.11
Q3 25
$-0.07
$0.00
Q2 25
$-0.05
$-0.01
Q1 25
$-0.07
$0.00
Q4 24
$-0.09
$-0.80
Q3 24
$-0.08
$-0.06
Q2 24
$-0.07
$-0.03
Q1 24
$-0.06
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
STXS
STXS
TACT
TACT
Cash + ST InvestmentsLiquidity on hand
$13.4M
$20.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$13.5M
$31.1M
Total Assets
$52.3M
$44.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
STXS
STXS
TACT
TACT
Q4 25
$13.4M
$20.4M
Q3 25
$10.5M
$20.0M
Q2 25
$7.0M
$17.7M
Q1 25
$10.6M
$14.2M
Q4 24
$12.2M
$14.4M
Q3 24
$10.7M
$11.3M
Q2 24
$14.7M
$11.1M
Q1 24
$17.6M
$10.6M
Stockholders' Equity
STXS
STXS
TACT
TACT
Q4 25
$13.5M
$31.1M
Q3 25
$6.3M
$31.8M
Q2 25
$1.5M
$31.3M
Q1 25
$2.9M
$30.9M
Q4 24
$6.1M
$30.6M
Q3 24
$10.8M
$38.4M
Q2 24
$11.4M
$38.5M
Q1 24
$14.6M
$38.6M
Total Assets
STXS
STXS
TACT
TACT
Q4 25
$52.3M
$44.8M
Q3 25
$45.6M
$45.0M
Q2 25
$41.2M
$44.5M
Q1 25
$45.7M
$44.2M
Q4 24
$46.7M
$44.0M
Q3 24
$50.9M
$50.5M
Q2 24
$36.0M
$50.4M
Q1 24
$39.5M
$51.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
STXS
STXS
TACT
TACT
Operating Cash FlowLast quarter
$-4.0M
$609.0K
Free Cash FlowOCF − Capex
$589.0K
FCF MarginFCF / Revenue
5.1%
Capex IntensityCapex / Revenue
0.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$7.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
STXS
STXS
TACT
TACT
Q4 25
$-4.0M
$609.0K
Q3 25
$-4.2M
$3.6M
Q2 25
$-3.7M
$3.6M
Q1 25
$-1.8M
$-161.0K
Q4 24
$1.3M
$2.4M
Q3 24
$-4.3M
$327.0K
Q2 24
$-3.1M
$636.0K
Q1 24
$-2.3M
$-1.5M
Free Cash Flow
STXS
STXS
TACT
TACT
Q4 25
$589.0K
Q3 25
$3.6M
Q2 25
$3.6M
Q1 25
$-171.0K
Q4 24
$2.4M
Q3 24
$-4.3M
$259.0K
Q2 24
$499.0K
Q1 24
$-1.6M
FCF Margin
STXS
STXS
TACT
TACT
Q4 25
5.1%
Q3 25
27.1%
Q2 25
25.9%
Q1 25
-1.3%
Q4 24
23.2%
Q3 24
-47.2%
2.4%
Q2 24
4.3%
Q1 24
-14.9%
Capex Intensity
STXS
STXS
TACT
TACT
Q4 25
0.2%
Q3 25
0.0%
0.5%
Q2 25
0.1%
Q1 25
0.1%
Q4 24
0.1%
Q3 24
0.1%
0.6%
Q2 24
1.2%
Q1 24
1.0%
Cash Conversion
STXS
STXS
TACT
TACT
Q4 25
Q3 25
242.00×
Q2 25
Q1 25
-8.47×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

STXS
STXS

Disposables Service And Accessories$5.3M61%
Systems$3.4M39%

TACT
TACT

Segment breakdown not available.

Related Comparisons